申请人:PHARMACOPEIA, INC.
公开号:US20030013720A1
公开(公告)日:2003-01-16
In one embodiment, this invention provides a novel class of compounds as antagonists of the MCH receptor, methods of preparing such compounds, pharmaceutical compositions containing one or more of the compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention or amelioration or one or more of diseases associated with the MCH receptor. An illustrative inventive compound is shown below:
1
在一个实施例中,这项发明提供了一类新型化合物,作为MCH受体的拮抗剂,包括制备这类化合物的方法,含有一种或多种这类化合物的药物组合物,制备包含一种或多种这类化合物的药物配方的方法,以及治疗、预防或改善与MCH受体相关的一种或多种疾病的方法。下面展示了一个说明性的创新化合物:
1